A practical class in the discipline ‘Biotechnology of Medicinal Plant Cultures’ is an opportunity for master’s students in specialty G21 ‘Biotechnologies and Bioengineering’ to examine the widely discussed problem of hemp cultivation and obtaining cannabinoids for medical use from the perspective of professionals. Thus, together with Prof. Liudmila Butsenko, students determined the contribution of biotechnology to solving the complex issues of medical cannabis production for the rehabilitation of military personnel and the development of domestic pharmaceutical industry through the use of non-psychotropic components.
In particular, they discussed biotechnological approaches to creating varieties and cultivating industrial and medicinal hemp in Ukraine, highlighting their versatility as an agricultural crop used in over 50 branches of the economy. “Modern Ukrainian scientists have succeeded in creating industrial hemp varieties with a record-low content of psychotropic substance (up to 0.08%), which allows them to hold first place in breeding worldwide” – Polishchuk Bohdan, PFB-1-1M.
They examined a complex of compounds unique to hemp – cannabinoids, which can be classified into 11 subclasses. And they found that hemp is a source not only of cannabinoids. “In addition to cannabinoids, the cannabis plant has over 400 identified non-cannabinoid components, classified into four main categories: non-cannabinoid phenols, flavonoids, terpenes, alkaloids. Terpenes are responsible for the smell and taste of hemp, while flavonoids affect not only the smell and taste, but also the unique color of each variety” – Kuznetsova Sofiya, PFB-1-1M.
An important question is determining the plant structures in which cannabinoid biosynthesis occurs, which affects the possibilities of obtaining cannabinoids by cultivating isolated hemp tissues in vitro. “The formation of cannabinoids is the responsibility of trichomes – these are specialized epidermal structures (hairs) of plants. In cannabis, they perform the function of secretory organs that synthesize and accumulate secondary metabolites, in particular cannabinoids. The largest number of secretory trichomes are found on the bracts and on the female flowers (inflorescences), while the stem and leaves are covered with non-secretory trichomes” – Kovinchenko Anastasiya, PFB-1-1M.
An interesting and relevant question was the possibility of carrying out heterologous expression of the cannabinoid pathway in yeast, bacteria, or Nicotiana benthamiana. “Biotechnological methods for obtaining cannabinoids using microorganisms and model plants are being developed. In genetically modified bacteria, particularly Escherichia coli, it is usually possible to obtain only cannabinoid precursors in small quantities due to the complexity of the biosynthetic pathway and the toxicity of products to the cell. More effective are yeasts such as Saccharomyces cerevisiae and Yarrowia lipolytica, which through the mevalonate pathway can synthesize cannabigerolic acid, however yields still amount to only a few mg/l. For the expression of individual enzymes, the model plant Nicotiana benthamiana is also used” – Bovtruk Anastasiya, PFB-1-1M.
The practical class became an opportunity to examine the controversial issue of today from different perspectives and confirmed that biotechnology is the key to solving current problems in modern medicine and pharmacy.






